← Back to Search

Behavioral Intervention

Children's Therapy for Emotional and Behavioral Issues

N/A
Recruiting
Led By Kristel Thomassin, PhD
Research Sponsored by University of Guelph
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change at post-test (after completion of the waitlist or intervention treatment; an average range 4 - 6 months)
Awards & highlights
No Placebo-Only Group

Summary

"This trial aims to understand how therapy helps children and adolescents aged 8-15 with anxiety, depression, trauma, or disruptive behavior. They want to know if managing negative emotions plays a role in how

Who is the study for?
This trial is for children aged 8-15 with anxiety, depression, trauma or disruptive behavior who speak English. Their parents must also speak English and be over 18. The study seeks to understand how therapy can help manage emotions in these children.
What is being tested?
The study tests a therapy called MATCH-ADTC against a waitlist control group to see if it helps kids better regulate negative emotions across various mental health issues. Participants will undergo assessments including interviews and experimental tasks.
What are the potential side effects?
Since this is a psychotherapy trial, there are no direct medical side effects like you'd expect from medication. However, discussing emotional topics may sometimes make participants feel uncomfortable or upset.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change at post-test (after completion of the waitlist or intervention treatment; an average range 4 - 6 months)
This trial's timeline: 3 weeks for screening, Varies for treatment, and change at post-test (after completion of the waitlist or intervention treatment; an average range 4 - 6 months) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in child emotional-behavioural problems
Change in child impairment
Change in child physiological emotion regulation (heart rate variability)
+5 more
Secondary study objectives
Change in child emotion regulation on a weekly basis
Change in child positive and negative affect
Change in child psychopathology symptoms on a weekly basis
+7 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention ArmExperimental Treatment1 Intervention
Treatment will be administered to participants in this arm.
Group II: Control ArmActive Control1 Intervention
No treatment will be administered to participants in this arm until post-test assessment has been completed.

Find a Location

Who is running the clinical trial?

Canadian Institutes of Health Research (CIHR)OTHER_GOV
1,393 Previous Clinical Trials
26,527,462 Total Patients Enrolled
3 Trials studying Trauma and Stressor Related Disorders
648 Patients Enrolled for Trauma and Stressor Related Disorders
University of GuelphLead Sponsor
84 Previous Clinical Trials
14,824 Total Patients Enrolled
Centre for Addiction and Mental HealthOTHER
375 Previous Clinical Trials
82,685 Total Patients Enrolled
Kristel Thomassin, PhDPrincipal InvestigatorUniversity of Guelph
~117 spots leftby Dec 2027
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top